NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 254 filers reported holding NATERA INC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,284,279 | -34.3% | 74,221 | -27.7% | 0.00% | -50.0% |
| Q2 2023 | $4,997,679 | -13.4% | 102,690 | -1.2% | 0.00% | 0.0% |
| Q1 2023 | $5,770,484 | +377549.5% | 103,971 | +173.3% | 0.00% | – |
| Q4 2022 | $1,528 | -99.9% | 38,049 | +4.9% | 0.00% | -100.0% |
| Q3 2022 | $1,589,000 | +16.4% | 36,259 | -5.7% | 0.00% | – |
| Q2 2022 | $1,365,000 | -75.0% | 38,468 | -71.4% | 0.00% | -100.0% |
| Q1 2022 | $5,466,000 | -53.7% | 134,342 | +6.2% | 0.00% | -50.0% |
| Q4 2021 | $11,814,000 | -6.7% | 126,507 | +11.3% | 0.00% | 0.0% |
| Q3 2021 | $12,659,000 | +15.2% | 113,641 | +17.5% | 0.00% | +33.3% |
| Q2 2021 | $10,985,000 | +33.0% | 96,731 | +18.9% | 0.00% | 0.0% |
| Q1 2021 | $8,260,000 | +61.6% | 81,348 | +58.4% | 0.00% | +50.0% |
| Q4 2020 | $5,111,000 | +627.0% | 51,356 | +428.0% | 0.00% | – |
| Q3 2020 | $703,000 | – | 9,727 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
| Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
| Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
| Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
| Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
| Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
| Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
| Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
| Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
| BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |